Phlogenzym (R) may prevent metabolic injuries to myocardium. Results of a laboratory experiment with rats

A Skutelis, E Pule, I Purvins, J Baltkajs, M Skromanis, M Zeibarts, J Osterreicher, J Ansbergs (Corresponding Author)

Research output: Contribution to journalArticlepeer-review

Abstract

To evaluate the possible cardio- and angioprotective efficacy of an orally administered enzyme preparation, Phlogenzym((R)), an experiment with laboratory animals was carried out. Metabolic injury to myocardium was initiated by injection of epinephrine. Morphological changes in tissue isolated from the hearts of control group animals were more marked compared with those in tissue from Phlogenzym((R))- treated animals. Furthermore, higher expression of transforming growth factor-P and more collagen fibers were found in tissue from the hearts of control animals. The least expressed changes were seen in tissue from animals pretreated and further treated with Phlogenzym((R)). We suggest that our findings support the assumption that Phlogenzym((R)) may prevent metabolic injury to myocardium, improve physiological tissue repair and prevent fibrosis formation.
Original languageEnglish
Pages (from-to)59-64
JournalINTERNATIONAL JOURNAL OF IMMUNOTHERAPY
Volume17
Issue number2-4
Publication statusPublished - 2001

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Phlogenzym (R) may prevent metabolic injuries to myocardium. Results of a laboratory experiment with rats'. Together they form a unique fingerprint.

Cite this